Maureen M. Goodenow, Ph.D.

Maureen M. Goodenow, Ph.D.
2016–2023

Maureen M. Goodenow, Ph.D., served Associate Director for AIDS Research at the National Institutes of Health (NIH) and Director of the NIH Office of AIDS Research (OAR) from 2016 to 2023. Dr. Goodenow was the first woman to serve as OAR Director since the office was established in 1988.

Effective March 26, 2023, Dr. Goodenow transitioned to a new role as Senior Advisor in the NIH Office of the Director. She continues to serve as Chief of the Molecular HIV and Host Interactions Section at the National Institute of Allergy and Infectious Diseases (NIAID).

During her transformational leadership of OAR, Dr. Goodenow coordinated an HIV research budget increase of over $250 million in five years, bringing the total NIH HIV research funding to over $3.2 billion in FY 2023. Additionally, she developed and implemented a five-year strategic plan for NIH HIV and HIV-related research FY 2021-2025; significantly improved HIV research priority alignment and funding accountability across the NIH Institute, Centers, and Offices; and helped NIH garner recognition of the importance of HIV research in the 2022-2025 National HIV/AIDS Strategy by working with the White House Office of National AIDS Policy.

Dr. Goodenow forged collaborations across the federal government, academia, and community and worked to ensure that the HIV research agenda continually responded to emerging science and evolving community needs. She initiated a new series of domestic and international listening sessions with the community to gather input to inform research priorities and directions. Under her leadership, OAR initiated multidisciplinary signature programs—on HIV and women, HIV and aging, and advancing technology—spanning across the missions of several NIH Institutes, Centers, and Offices.

Prior to joining NIH in May 2016, Dr. Goodenow was a tenured professor of pathology, immunology, and laboratory medicine at the University of Florida College of Medicine, where she was named the first Stephany W. Holloway Endowed Professor for HIV and AIDS Research. She also served as a Jefferson Science Fellow in health economics in the Asia/Pacific region at the U.S. Department of State, and as a special advisor to the Global AIDS Coordinator and the President's Emergency Plan for AIDS Relief (PEPFAR) program. Additionally, from 2015 to 2016, she served as Acting Director of the Office for Research and Science within the U.S. Department of State, Office of the U.S. Global AIDS Coordinator and Office of Global Health Diplomacy.

Dr. Goodenow received her undergraduate degree in Biology from Fordham University and her Ph.D. in Molecular Genetics from the Albert Einstein College of Medicine.